Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.
Journal
Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035
Informations de publication
Date de publication:
14 Jul 2023
14 Jul 2023
Historique:
pubmed:
28
7
2023
medline:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
The clinical development of farnesyltransferase inhibitors (FTI) for
Identifiants
pubmed: 37503077
doi: 10.21203/rs.3.rs-3154719/v1
pmc: PMC10371077
pii:
doi:
Types de publication
Preprint
Langues
eng
Déclaration de conflit d'intérêts
Competing Interest Statement: No additional competing interests to disclose